Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5880218 | The Journal of Pain | 2014 | 6 Pages |
Abstract
This article showed that INFS and FPNS in doses proportional to basal opioid regimen are equally safe and effective for the management of breakthrough pain in cancer patients. These data provide new insights on the use of nasal preparations of fentanyl.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sebastiano Mercadante, Giovanna Prestia, Claudio Adile, Alessandra Casuccio,